News and Insights
The Numerof 2017 Global Medical Device Outlook
As our Numerof 2017 Global Medical Device Outlook infographic illustrates, this year’s story for medical device manufacturers will be about dramatically changing roles and relationships. You’ll continue to engage in new and different ways with regulators, public and private payers, consumers, employers, health care delivery, physicians, retail clinics, and even pharmaceutical manufacturers.
Regulators will continue tough enforcement, including expansion of the adverse event reporting universe. Globally, cost effectiveness evidence will play an ever more significant role in approvals. Meanwhile, in the U.S., political and legislative uncertainty will create risk and opportunity. However, progress on expediting pre-market approvals will continue. Government payers worldwide will insist on transparency for comparative quality and pricing, as well as comparative effectiveness research, real world evidence and risk-based pricing.
Demanding evidence of better outcomes and lower costs, private payers will also expand direct purchasing of devices, value-based contracting and reference pricing. Consumers will get more involved in choosing diagnostic tests as they also shop for lower cost, higher quality procedures. Employers seeking to reduce surgical and procedure costs will push providers for more direct contracting and bundled prices, impacting medical device makers.
In the U.S., although physician employment by systems is stabilizing, healthcare delivery continues to centralize buying decisions in cross functional committees. However, new, high-level collaboration opportunities continue as they seek ways to decrease costs and improve outcomes. Better positioning with integrated delivery networks (IDNs) will be key to future success.
Given this outlook, what’s next? We recommend these key action steps:
- Focus development efforts on high value products backed by evidence
- Innovate new products for use in less intensive sites across the care continuum
- Redesign commercial models to reach the new IDN customer
- Align R&D, Medical Affairs, and Commercial functions
- Craft compelling economic & clinical value propositions
- Recruit, train talent to engage executive decision makers
- Elevate business acumen, diagnostic and influence skills
- Meet customer needs with value added services
- Create collaboration opportunities with payers and providers
At Numerof & Associates, we help medical device manufacturers achieve these key action steps for success in today’s evolving healthcare landscape. From competitive strategy and value to commercial model implementation, we have solutions. Read more about our perspectives and solutions for the medical device industry and see our case studies.